Impact of age and induction therapy on outcome of 180 adult patients with acute myeloid leukemia; retrospective analysis and literature review

The prognosis of acute myeloid leukemia (AML) remains poor. Among 180 patients, the median age was 53 (14-88) years. The overall 2-year disease free survival (DFS) was 28.6% (+/- 3.4), 47.7% (+/- 6.6%) for ≤ 40, 23.6% (+/- 5.8%) for 41–60 and 11.7% (+/- 4.2%) for ≥61 (p< 0.0001). The overall 2-ye...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leuk Res Rep
Main Authors: Abuelgasim, Khadega A., Albuhayri, Bandar, Munshi, Rayan, Mugairi, Areej Al, Alahmari, Bader, Gmati, Giamal, Salama, Hind, Alzahrani, Mohsen, Alhejazi, Ayman, Alaskar, Ahmed, Damlaj, Moussab
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7296329/
https://ncbi.nlm.nih.gov/pubmed/32566477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lrr.2020.100206
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados